66213-421 : Donnatal (Atropine Sulfate 0.0582 mg / Hyoscyamine Sulfate 0.311 mg / Phenobarbital 48.6 mg / Scopolamine Hydrobromide 0.0195 mg) Extended Release Tablet


NDC: 66213-421
Labeler: Pbm Pharmaceuticals, Inc
Product Type: Human Prescription Drug
Drug Name:  Donnatal Extentabs
Dosage Form: Oral Tablet, Film Coated, Extended Release
Rev. Date: 


Appearance:


Markings: P;421 OR 421
Shapes:  Round
Colors:  Green
Size (mm): 10
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

P 421 OR 421: (66213-421) Donnatal (Atropine Sulfate 0.0582 mg / Hyoscyamine Sulfate 0.311 mg / Phenobarbital 48.6 mg / Scopolamine Hydrobromide 0.0195 mg) Extended Release Tablet by Pbm Pharmaceuticals, Inc
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 66213-421-10: 100 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (66213‑421‑10)
  • 66213-421-50: 500 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (66213‑421‑50)

Active Ingredients:

  • Atropine Sulfate
  • Hyoscyamine Sulfate
  • Phenobarbital
  • Scopolamine Hydrobromide

Dosage Strength:

  • .0582 mg
  • .3111 mg
  • 48.6 mg
  • .0195 mg

Inactive Ingredients:

  • Anhydrous Lactose
  • Calcium Sulfate, Unspecified
  • Silicon Dioxide
  • Calcium Phosphate, Dibasic, Anhydrous
  • Lactose Monohydrate
  • Magnesium Stearate
  • Stearic Acid
  • D&c Yellow No. 10
  • Fd&c Blue No. 1
  • Hypromellose 2208 (4000 Mpa.s)
  • Polydextrose
  • Polyethylene Glycol 2000
  • Titanium Dioxide
  • Triacetin

Pharmaceutical Classes:

  • Anticholinergic [EPC]
  • Cholinergic Antagonists [MoA]
  • Cholinergic Muscarinic Antagonist [EPC]
  • Cholinergic Muscarinic Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 65084-450 Donnatal (Atropine Sulfate 0.0582 mg / Hyoscyamine Sulfate 0.311 mg / Phenobarbital 48.6 mg / Scopolamine Hydrobromide 0.0195 mg) Extended Release Tablet by Rxpak Division of Mckesson Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 66213-421 QR Code

< Prev: 66213-200Next: 66213-422 >

Related Discussions:

hyoscyamine sulfate
irritable bowel , and ulcers ## Hyoscyamine is used to provide symptomatic relief to various gastrointestinal disorders ... 3 replies
hyoscyamine sulfate 125mg and excessive salivation
How long does it take for hyoscyamine sulfate to work if you are using it for excessive salivation? ## Most medications ... 1 reply
Taking Hyoscyamine Sulfate 125 Mg With Lorazepam 1mg
is it safe to take hyoscyamine sulfate 125 mg with lorazepam? ## I didn't find any interactions or problems listed b... 1 reply
Why Is There A Shortage Of Donnatal Extentabs
Why Is There A Shortage Of Donnatal Extentabs? I am told that there is a back order until June 2013. How is this possibl... 10 replies
Does anyone know where I might be able to find Donnatal Extentabs these days?
I've exhausted all resources to obtain this medication and now I am having problems finding the regular Donnatal tab... 2 replies
DIPHENOXYLATE HC/AND ATROPINE SULFATE?
WHITE TABLET STOPS DIARRHEA WHAT IS THE BRAND NAME? IT'S HARD FOR ME TO REMEMBER THE NAME.IF IT HAS A SHORTER NAME P... 3 replies
Phenobarbital Shortage??
I am having trouble getting phenobarbital from the pharm due to lack of supply. Anyone else having this issue? ## Hello,... 42 replies
Phenobarbital and Myrbetriq
I was prescribed Myrbetriq for a spasmatic bladder, but it is not working and I stopped taking it. The pharmacist says i... 5 replies
phenobarbital 30 mg
Is there a change in the dosage of phenobarbital 30 mg and if so why aren't pharmacies and doctors on the same page.... 5 replies
phenobarbital shelf life
Does a ten year old pill still have any potensy ## Most likely not. Even those still sealed in the original factory cont... 4 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.